Clinical Trial Update: Side Population in Pancreatic Ductal Adenocarcinoma (PDAC)

View source ↗

Summary

Completed clinical trial investigating the side population in pancreatic ductal adenocarcinoma (PDAC) to characterize its properties.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: University Hospital, Gasthuisberg | Conditions: Neoplasm, Pancreas | Status: COMPLETED